Codexis ( ($CDXS) ) has released its Q3 earnings. Here is a breakdown of the information Codexis presented to its investors. Codexis, Inc. is a ...

Committee seeks stronger trial design, urging SII to sharpen objectives and raise scientific standards for proving CERVAVAC’s ...

Thierry André and colleagues recently reported that nivolumab–ipilimumab provided an impressive absolute progression-free survival benefit at 36 months, which was 17% compared with nivolumab ...

Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED technology and materials, today announced that it has entered into a defini ...

Universal Display acquires Merck's OLED patent assets, boosting innovation with 300+ patents. Learn how this move impacts the OLED market.

The Cambridge company has aggressively reduced costs through measures including staff cuts and lower spending on research and ...

Muscle-invasive bladder cancer management is challenging for cisplatin-ineligible patients due to limited treatment options and high recurrence rates. The Padcev-Keytruda combination therapy ...

Ligand is increasing its 2025 full year financial guidance. The Company now expects total core revenue of $225 million to ...

Merck's power purchase agreement (PPA) with SK Innovation E&S will supply 16 megawatts of renewable electricity to life ...

German diversified group Merck KGaA is preparing to put its pigments business up for sale to fund investments at its drugs ...

Germany's Merck KGgA said on Monday it has agreed to pay Swiss biotech Debiopharm up to 900 million euros ($1.08 billion) to ...